Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease.

Autor:	Park, Steven I., Shenoi, Jaideep, Pagel, John M., Hamlin, Donald K. *, Orgun, Nural *, Kenoyer, Aimee L. *, Wilbur, Shani M. *, Axtman, Amanda *, Wilbur, D. Scott *, Lin, Yukang *, Fisher, Darrell R. *, Gopal, Ajay K., Green, Damian J., Press, Oliver W.
Zdroj:	In Blood 20 November 2009 114(22):2705-2705
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu